Nanosyn

Nanosyn is a U.S.-based, full-service CDMO founded in 1999, offering comprehensive drug discovery and development services including medicinal chemistry, process R&D, cGMP API manufacturing, and specialized biology assays. The company operates from three state-of-the-art facilities in the San Francisco Bay Area, totaling over 100,000 square feet, and boasts a team with deep industry experience from major pharmaceutical firms. It has completed over 50,000 projects for a diverse range of clients, from academia to Top 50 Pharma, emphasizing rapid turnaround, technical expertise, and collaborative problem-solving. Nanosyn was acquired by and is now part of Element Materials Technology, enhancing its scale and resources.

Integrated CDMO services leveraging advanced chemistry, biology (including microfluidic mobility shift kinase assays), and cGMP manufacturing technologies.

Nanosyn competes in a fragmented but competitive CDMO market, contending with large global players (e.g., Lonza, Catalent) and many specialized chemistry/biology service providers. Its differentiation lies in its integrated service offering, deep technical expertise, rapid turnaround, and strategic location in the San Francisco Bay Area biotech hub.